# OnCo record sibylle-loibl (person). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/people/sibylle-loibl/>
  a schema:Person ;
  onco:kind "person" ;
  schema:identifier "sibylle-loibl" ;
  schema:name "Sibylle Loibl"@en ;
  schema:description "Leads the German Breast Group, whose GeparX trials defined neoadjuvant chemotherapy and immunotherapy in breast cancer."@en ;
  schema:url <https://onco.cc/people/sibylle-loibl/> ;
  schema:dateModified "2026-09-08"^^xsd:date ;
  schema:citation <https://www.gbg.de/>, <https://pubmed.ncbi.nlm.nih.gov/?term=Loibl%20S%5BAuthor%5D%20neoadjuvant%20breast> ;
  schema:jobTitle "Chief Executive Officer and Chair, German Breast Group" ;
  onco:cancers <https://onco.cc/cancers/tnbc/>, <https://onco.cc/cancers/breast-her2-positive/> ;
  onco:drugs <https://onco.cc/drugs/carboplatin/>, <https://onco.cc/drugs/durvalumab/> ;
  onco:companies <https://onco.cc/companies/gbg/> ;
  onco:terms <https://onco.cc/terms/pcr/> ;
  schema:affiliation <https://onco.cc/companies/gbg/> .
